Tropical Disease Development Partnerships Want More Help From U.S. FDA
This article was originally published in PharmAsia News
The agency’s infrastructure is not attracting many of the Product Development Partnership sponsors, Aeras official says, but new draft guidance could help.
You may also be interested in...
At user fee hearing, PhRMA’s Wheadon counters questions from Rep. Dingell, saying FDA already is receiving resources to conduct GMP inspections outside the U.S.
FDA has its own programs, but a State Department undersecretary said enhancing training at FDA could boost efforts to fight drug counterfeiting and diversion.
Georgetown, Maryland gain CERSI grants in part because of their proximity to agency staff.